We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

75 hedge funds and large institutions have $385M invested in Coherus Oncology in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 17

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

0% more capital invested

Capital invested by funds: $384M → $385M (+$1.23M)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

3% less funds holding

Funds holding: 77 → 75 (-2)

Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
17
Increased
28
Reduced
17
Closed
18
Calls
$87K
Puts
–
Net Calls
+$87K
Net Calls Change
+$237K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.7M
2
JP Morgan Chase
JP Morgan Chase
New York
+$7.64M
3
Axa
Axa
France
+$7.35M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.25M
5
BM
Bridger Management
New York
+$5.59M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$8.43M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$6.52M
3
HCMT
Highland Capital Management (Texas)
Texas
-$5.13M
4
PHS
PFM Health Sciences
California
-$3.96M
5
SFM
Soros Fund Management
New York
-$2.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
IHM
26
Iguana Healthcare Management
New York
$2.12M +$410K +25,000 +33%
BIM
27
BlackRock Investment Management
Delaware
$1.78M +$27.9K +1,702 +2%
Handelsbanken Fonder
28
Handelsbanken Fonder
Sweden
$1.17M -$1.64M -100,000 -65%
Charles Schwab
29
Charles Schwab
California
$1.08M +$10.9K +663 +1%
EAM
30
EverPoint Asset Management
Connecticut
$1.06M +$819K +50,000 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$103K +6,280 +14%
Morgan Stanley
32
Morgan Stanley
New York
$750K +$519K +31,690 +879%
ProShare Advisors
33
ProShare Advisors
Maryland
$676K -$47.2K -2,879 -8%
AllianceBernstein
34
AllianceBernstein
Tennessee
$599K -$96.7K -5,900 -17%
CS
35
Credit Suisse
Switzerland
$592K -$98.8K -6,029 -18%
Swiss National Bank
36
Swiss National Bank
Switzerland
$591K +$86.8K +5,300 +23%
Franklin Resources
37
Franklin Resources
California
$531K – – –
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$493K – – –
CA
39
Commerzbank Aktiengesellschaft
Germany
$490K +$378K +23,068 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$479K +$1.72K +105 +0.5%
Citigroup
41
Citigroup
New York
$363K +$185K +11,273 +194%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$344K +$265K +16,185 +107,900%
NFA
43
Nationwide Fund Advisors
Ohio
$328K -$11.7K -715 -5%
DekaBank Deutsche Girozentrale
44
DekaBank Deutsche Girozentrale
Germany
$321K +$274K +16,700 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$314K +$2.95K +180 +1%
HI
46
Handelsinvest Investeringsforvaltning
Denmark
$301K – – –
AIG
47
American International Group
New York
$293K – – –
Wells Fargo
48
Wells Fargo
California
$283K +$71.9K +4,388 +49%
TC
49
TFS Capital
Pennsylvania
$280K +$216K +13,167 New
HCM
50
Highbridge Capital Management
New York
$256K +$198K +12,064 New
1
2
3 4

CHRS Hedge Fund Activity: Q1 2016 in Review

75 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2016, worth a combined $385M — up 0.32% from $384M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CHRS and 17 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 28 added.

The largest buyer was Fidelity Investments, adding an estimated $12.7M. The largest seller was Jennison Associates, exiting entirely with an estimated $8.43M sold.

  • 75 institutional investors held Coherus Oncology (CHRS) as of Q1 2016, down from 77 in Q4 2015.
  • Funds reported $385M of Coherus Oncology stock for Q1 2016, up 0.32% quarter-over-quarter.
  • 17 funds opened new Coherus Oncology positions in Q1 2016 and 18 closed out, a net change of -1 holder.
  • The largest Coherus Oncology buyer in Q1 2016 was Fidelity Investments, an estimated $12.7M added.
  • The largest Coherus Oncology seller in Q1 2016 was Jennison Associates, an estimated $8.43M sold.

Based on aggregated 13F filings for Q1 2016.